Navigation Links
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Date:12/9/2012

hat had previously shown limited utility for patients with myelofibrosis.

Myelofibrosis is a chronic malignant blood disorder commonly caused by mutations in the JAK2 pathway (which normally signals the body to create blood cells), including most commonly the JAK2 V617F mutation. This mutation leads to the overproduction of scar tissue in the bone marrow and shifts red and white blood cells and platelets from the bone marrow into the spleen and liver, enlarging the organs and leading to anemia, infection, inflammation, and easy bleeding and bruising.

The first approved treatment for myelofibrosis is ruxolitinib, a therapy that targets the JAK2 mutation by blocking the action of all JAK-related genes in the body, including those from both healthy and diseased cells. However, clinical results have been modest to date. In particular, resistance to JAK inhibitors has been associated with an increase in JAK2 levels, which leads to continued JAK2 activity despite ruxolitinib treatment. This resistance can be reversed by inhibiting heat shock protein 90 (HSP 90), which destabilizes JAK2 and reduces JAK2 protein levels. Since cancer cells are continually dividing, they constantly burden the cell system and depend on HSP90 function to allow the JAK2 protein to maintain cancer cells' function and growth.

Recognizing HSPs as a potential target for treatment, researchers have recently explored the possibility of blocking HSP90 to treat blood cancers. Unlike ruxolitinib, which blocks the function of the abnormal JAK2 protein that maintains the function of the cancerous cell, HSP90 inhibitors block the function of HSP90 in the cells. This allows for the breakdown of the JAK2 protein and weakens the cell's ability to grow and divide, allowing it to become sensitive to treatment. PU-H71, a HSP90 inhibitor, previously shown to have efficacy in different cancer cells and animal models including myelofibrosis, is currently undergoing Phase I clinical trials
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Researchers develop novel 3-D culture system for inflammatory breast cancer
2. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
3. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
4. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
5. Novel breast screening technology increases diagnostic accuracy
6. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
7. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
8. Novel treatment strategies for epilepsy
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
11. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 Bringing ... Profit By Search announces the Labor Day discount ... clients will surely get the complete services related to ... SEO professionals, Content Writers, and others do have a ... perfection that reflects in their work and since the ...
(Date:8/30/2014)... "I had a handicapped friend who could not walk ... from Wetumpka, Ala. "In order to help her be able ... came up with a way for her to use her ... the patent-pending Deezers to allow crutches to be used on ... walkers, or canes at the beach. The device reduces the ...
(Date:8/30/2014)... Bethesda, MD (PRWEB) August 30, 2014 In ... and increasingly difficult to get. Snoring and sleep apnea (a ... stops) robs people and their bed partners of the rest ... to 45% of the population snores and 20 million people ... only 10% have been diagnosed and treated; and of those ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 One of the ... era is the gluten-free diet. Originally meant for sufferers of ... a catchall for people who are looking to get healthier ... not only is this kind of information erroneous, it also ... problems because of a drastic change in their food ...
Breaking Medicine News(10 mins):Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2
... 21 As the pace of global,competition ... research,groups to keep up. Effective market research ... customers, markets and competitors as,reference points to ... from benchmarking leader Best Practices, LLC., ...
... got easier and a lot more accessible to the public ... a ground-breaking partnership between a young British entrepreneur, a global ... , Debuted April 20 to offer individuals a meaningful way ... hope www.MalariaEngage.org will do for African research what ...
... Don,t eat for 2, because complications increase with excess weight, ... been considered a kind of gastronomical free-for-all. After all, ... food she eats, right? , The problem is, the ... and extra weight gain can increase the risk of pregnancy ...
... J. Deitsch, Chairman,and Chief Executive Officer of Nutra ... will be updating the investment,community through his personal ... dynamic profile will include exclusive interviews with,Rik J. ... his personal,stock watchlist, photos of company products and ...
... Sales force performance,significantly impacts growth and ... to effectively disseminate vital information to their ... to the overall success of,their companies., ... Excellence:,Resources, Structure and Processes to Optimize Pharmaceutical ...
... point to the brain-draining effects of decision-making , , FRIDAY, April ... flavors of ice cream, people,s lives are full of choices. ... sap your stamina, your ability to stay focused and even ... people faced with a variety of choices had more trouble ...
Cached Medicine News:Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:International health experts to enlist the public in war on African malaria 2Health News:International health experts to enlist the public in war on African malaria 3Health News:International health experts to enlist the public in war on African malaria 4Health News:International health experts to enlist the public in war on African malaria 5Health News:International health experts to enlist the public in war on African malaria 6Health News:International health experts to enlist the public in war on African malaria 7Health News:International health experts to enlist the public in war on African malaria 8Health News:Extra Pounds During and Between Pregnancies Can Pose Problems 2Health News:Extra Pounds During and Between Pregnancies Can Pose Problems 3Health News:Rik Deitsch, CEO of Nutra Pharma Creates Personal Wall on WallSt.net's Financial Social Community, my.wallst.net 2Health News:Complementary Excerpt Available from Best Practices: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications 2Health News:Choices Sap Your Stamina, Self Control: Study 2Health News:Choices Sap Your Stamina, Self Control: Study 3
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Research and Development Trend Forecast of Pharmaceutical ... offering. Research and Development Trend Forecast ... , 2014-2018 mainly analyzes China,s ... status, supply & demand, competition landscape, and business performance ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... Executive Officer, will present at the 23 rd ... City at the New York Palace Hotel.  The presentation ...
... 23, 2011 Reportlinker.com announces that ... available in its catalogue: ... Devices Industry 2011–2012: Market Trends and ... Devices Industry Procurement and Marketing Initiatives ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference 2Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 2Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 3Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 4Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 5Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 6Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 7Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 8Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 9Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 10Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 11Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 12Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 13Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 14Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 15
... Difficile Tox A/B II is a second-generation rapid ... A and B in fecal specimens. The test ... results detecting not only the more common toxin ... A-/B+. It's easy to perform, produces no indeterminates ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
Medicine Products: